Laura Rodriguez

Multicomponent polysaccharide–protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c7sc05467j

Daniel G. Rivera, Aldrin V. Vasco, Y. Méndez, 2018, Chemical science.

A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles

J. L. Pérez, Guang-Wu Chen, L. González, 2021, RSC chemical biology.

Relevance of O-acetyl and phosphoglycerol groups for the antigenicity of Streptococcus pneumoniae serotype 18C capsular polysaccharide.

Janoi Chang, Raine Garrido, Jessy Pedroso, 2012, Vaccine.

Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme.

N. Omeiri, S. Borroto Gutiérrez, A. Clark, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies.

K. Leon, R. Oliva, Guang-Wu Chen, 2021, ACS chemical biology.

SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studies

R. Oliva, Guang-Wu Chen, L. González, 2021, bioRxiv.

A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles †‡ RSCChemical Biology

J. L. Pérez, Guang-Wu Chen, Y. Ramos, 2022 .

Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines

K. Leon, Guang-Wu Chen, Daniel G. Rivera, 2021, ACS central science.

A cell-based ELISA as surrogate of virus neutralization assay for RBD SARS-CoV-2 specific antibodies

Laura Rodriguez, D. García-Rivera, María Teresa Pérez, 2022, Vaccine.